The growth of the Cerebrospinal Fluid (CSF) Management Market is primarily driven by the rising incidence of neurological disorders such as hydrocephalus, brain injuries, and spinal cord conditions, which require effective management. Advancements in medical devices, including innovative CSF shunts and drainage systems, have improved treatment outcomes, further driving market expansion.
, /PRNewswire/ — The global Cerebrospinal Fluid (CSF) Management Market is expected to grow from USD 2.5 billion in 2024 to USD 3.8 billion by 2031, at a compound annual growth rate (CAGR) of 6.2%. This growth is driven by the increasing prevalence of neurological conditions, advancements in CSF management devices, and rising awareness of timely treatment for disorders like hydrocephalus.
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1038984
202 – Pages
126 – Tables
37 – Figures
Scope Of The Report
REPORT ATTRIBUTES |
DETAILS |
STUDY PERIOD |
2020-2031 |
BASE YEAR |
2023 |
FORECAST PERIOD |
2024-2031 |
HISTORICAL PERIOD |
2020-2023 |
UNIT |
Value (USD Billion) |
KEY COMPANIES PROFILED |
Medtronic, Johnson & Johnson, Integra LifeSciences, Spiegelberg, Codman & Shurtleff (Johnson & Johnson), B. … |